{"result": "(\"entity\"<|>ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE<|>ORGANIZATION<|>A group representing various pediatric endocrinology societies involved in the consensus guidelines for congenital hypothyroidism.)\n##\n(\"entity\"<|>CONGENITAL HYPOTHYROIDISM CONSENSUS CONFERENCE GROUP<|>ORGANIZATION<|>A group that convenes to establish guidelines for the screening, diagnosis, and treatment of congenital hypothyroidism.)\n##\n(\"entity\"<|>EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY<|>ORGANIZATION<|>A professional organization focused on pediatric endocrinology, involved in creating consensus guidelines.)\n##\n(\"entity\"<|>HYPERTIROIDISM<|>EVENT<|>A medical condition characterized by excessive thyroid hormone production, discussed in the context of its clinical implications and management.)\n##\n(\"entity\"<|>GRAVES' DISEASE<|>EVENT<|>An autoimmune disorder that is a common cause of hyperthyroidism, with specific clinical manifestations and treatment considerations.)\n##\n(\"entity\"<|>HORM RES PEDIATR<|>ORGANIZATION<|>A journal that publishes research related to pediatric endocrinology, including studies on congenital hypothyroidism.)\n##\n(\"entity\"<|>J CLIN ENDOCRINOL METAB<|>ORGANIZATION<|>A journal that publishes clinical research in endocrinology, including studies on hyperthyroidism and its effects.)\n##\n(\"entity\"<|>ARCH INTERN MED<|>ORGANIZATION<|>A medical journal that publishes research on internal medicine, including studies related to thyroid disease.)\n##\n(\"entity\"<|>EUR J ENDOCRINOL<|>ORGANIZATION<|>A journal that publishes research in endocrinology, including studies on the pathophysiology of Graves' disease.)\n##\n(\"entity\"<|>AUTOIMMUN REV<|>ORGANIZATION<|>A journal that focuses on autoimmune diseases, including research on thyroid autoimmunity.)\n##\n(\"relationship\"<|>ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE<|>CONGENITAL HYPOTHYROIDISM CONSENSUS CONFERENCE GROUP<|>Both entities are involved in the development of guidelines for congenital hypothyroidism<|>7)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY<|>CONGENITAL HYPOTHYROIDISM CONSENSUS CONFERENCE GROUP<|>The European Society for Paediatric Endocrinology is a key contributor to the consensus guidelines<|>8)\n##\n(\"relationship\"<|>HYPERTIROIDISM<|>GRAVES' DISEASE<|>Graves' disease is a common cause of hyperthyroidism, linking the two medical conditions<|>9)\n##\n(\"relationship\"<|>HYPERTIROIDISM<|>ARCH INTERN MED<|>Research published in Arch Intern Med may include studies on hyperthyroidism and its clinical implications<|>5)\n##\n(\"relationship\"<|>GRAVES' DISEASE<|>EUR J ENDOCRINOL<|>Research on Graves' disease is often published in the European Journal of Endocrinology<|>6)\n##\n(\"relationship\"<|>HORM RES PEDIATR<|>CONGENITAL HYPOTHYROIDISM CONSENSUS CONFERENCE GROUP<|>Research on congenital hypothyroidism is published in Horm Res Pediatr, which is relevant to the guidelines<|>6)\n##\n(\"relationship\"<|>J CLIN ENDOCRINOL METAB<|>HYPERTIROIDISM<|>Studies on hyperthyroidism are published in the Journal of Clinical Endocrinology and Metabolism<|>5)\n##\n(\"relationship\"<|>AUTOIMMUN REV<|>GRAVES' DISEASE<|>Research on autoimmune aspects of Graves' disease is published in Autoimmunity Reviews<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: van Vliet G, et al, on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, and           que aparece virtualmente en todos los pacientes con hipertiroidismo. Repercusiones car-\n                 the Congenital Hypothyroidism Consensus Conference Group. European Society for Paediatric Endocrinology Consensus Guidelines                diovasculares con mayor trascendencia clínica como la fibrilación auricular son infrecuentes\n                 of screening, diagnosis and treatment of congenital hypothyroidism. Horm Res Pediatr. 2014;81:80-103.                                       en menores de 60 años, pero aparecen en más de un 10% de los mayores de 60                                         años.\n                                                                                                                                                             Referencias:\n     3.2 Hipertiroidismo                                                                                                                                     • Boelaert K, Torlinska B, Holder RL, Franklyn JA. Older subjects with hyperthyroidism present with a paucity of symptoms and signs:\n                                                                                                                                                               a large cross-sectional study. J Clin Endocrinol Metab. 2010;95:2715-26.\n                                                                                                                                                             • Brix TH, Hansen PS, Kyvik KO, Hegedus L. Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin\n                                                                                                                                                               case-control study. Arch Intern Med. 2000;160:661-6.\n                                                                                                                                                             • Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116:1725-35.\n         8     ¿Cuál de los siguientes datos clínicos no es concordante con la enfermedad                                                                    • Falgarone G, Heshmati HM, Cohen R, Reach G. Role of emotional stress in the pathophysiology of Graves’ disease. Eur J Endocrinol.\n               de Graves?                                                                                                                                      2013;168 R13-8.\n                                                                                                                                                             • Granada ML, Rodríguez-Espinosa J. Interferencias por anticuerpos en la valoración bioquímica de la función tiroidea. Endocrinol Nutr.\n                                                                                                                                                               2000;47:71-2.\n               A. Anticuerpos antilevotiroxina (T4) positivos.                                                                                               • Lidz T. Emotional factors in the etiology of hyperthyroidism. The report of a preliminary survey. Psychosom Med.1949;11:2-8.\n               B. Mixedema pretibial en el 5-10% de los pacientes.                                                                                           • Smith TJ, Hegedus L. Graves’ disease. N Engl J Med. 2016;375:1552-65.\n                                                                                                                                                             • Tozzoli R, Bagnasco M, Giavarina D, Bizzaro N. TSH receptor autoantibody immunoassay in patients with Graves’ disease: impro-\n               C. El estrés y el tabaquismo son factores ambientales asociados a la enfermedad.                                                                vement of diagnostic accuracy over different generations of methods: systematic review and meta-analysis. Autoimmun Rev.\n                                                                                                                                                               2012;12:107-13.\n               D.   La manifestación cardiovascular más frecuente es la taquicardia sinusal.\n\n\n\n               COMENTARIO                                                                                                                                 9  Con respecto          a la oftalmopatía de Graves, señale la opción correcta:\n               La enfermedad de Graves es una enfermedad autoinmunitaria cuyas manifestaciones clínicas                                                      A.   La retracción palpebral puede ocurrir en hipertiroidismos no asociados a la enfermedad\n               son debidas a anticuerpos circulantes que se unen al receptor de la TSH, lo que causa hiperti-                                                     de Graves.\n               roidismo y bocio. Estos anticuerpos son fundamentalmente IgG1 que se unen a un epítopo rico                                                   B. En el 80% de los pacientes, la oftalmopatía coincide con el diagnóstico del\n               en leucina del dominio extracelular del receptor de TSH. La sensibilidad y especificidad para                                                      hipertiroidismo.\n               detectar enfermedad de Graves con la determinación de estos anticuerpos con métodos de 2.ª y                                                  C. La grave suele responder a glucocorticoides a dosis bajas (prednisona 10 mg/día).\n               3.ª generación llega al 97% y 98%, respectivamente.                                                                                           D.   Todas las respuestas son falsas.\n               La presencia de anticuerpos antihormonas tiroideas es una situación de frecuencia no bien\n               establecida en la población general, cuya principal repercusión es producir interferencias\n\n\n\n148                                                                                                                                                                                                                                                                                               149\n---\n                                                                                                                                                                                                                                                      TIROIDES                           3\n\n\n\n         COMENTARIO                                                                                                                                      la producción excesiva de hormonas tiroideas es producto bien de una hiperactividad de\n         La oftalmopatía de Graves es una enfermedad inflamatoria ocular que se desarrolla en la                                                         las células tiroideas, bien de una mayor cantidad de parénquima tiroideo funcionante, por\n         órbita asociada con enfermedad tiroidea autoinmune, fundamentalmente enfermedad de                                                              lo que el hipertiroidismo se etiqueta como primario.\n         Graves.                                                                                                                                         Sin embargo, en el caso de tumores secretores de gonadotropina coriónica, el hipertiroidis-\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}